Alison N. McCracken

435 total citations
13 papers, 243 citations indexed

About

Alison N. McCracken is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Alison N. McCracken has authored 13 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Organic Chemistry. Recurrent topics in Alison N. McCracken's work include Sphingolipid Metabolism and Signaling (9 papers), Lipid Membrane Structure and Behavior (4 papers) and Calcium signaling and nucleotide metabolism (2 papers). Alison N. McCracken is often cited by papers focused on Sphingolipid Metabolism and Signaling (9 papers), Lipid Membrane Structure and Behavior (4 papers) and Calcium signaling and nucleotide metabolism (2 papers). Alison N. McCracken collaborates with scholars based in United States, Canada and Switzerland. Alison N. McCracken's co-authors include Aimee L. Edinger, Stephen Hanessian, Brendan T. Finicle, Rebecca Fransson, Saurabh G. Roy, Bin Chen, Seong Min Kim, Michael T. Kleinman, Bin Chen and Andrea Huwiler and has published in prestigious journals such as Nucleic Acids Research, Oncogene and Journal of Cell Science.

In The Last Decade

Alison N. McCracken

13 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison N. McCracken United States 9 175 38 32 29 27 13 243
Kyoung‐Soo Choi United States 8 257 1.5× 25 0.7× 24 0.8× 32 1.1× 24 0.9× 10 345
Sheik Pran Babu Sardar Pasha United States 10 177 1.0× 29 0.8× 12 0.4× 22 0.8× 13 0.5× 15 280
Yi Liao China 10 230 1.3× 24 0.6× 24 0.8× 10 0.3× 15 0.6× 22 328
Silvia Radenkovic United States 9 159 0.9× 50 1.3× 18 0.6× 16 0.6× 8 0.3× 26 216
Jennifer Bolsée Belgium 8 212 1.2× 39 1.0× 8 0.3× 20 0.7× 41 1.5× 13 303
Joshua Bliesath United States 8 251 1.4× 39 1.0× 26 0.8× 10 0.3× 23 0.9× 8 333
Jicheng Duan United States 7 284 1.6× 17 0.4× 24 0.8× 64 2.2× 69 2.6× 11 395
Robert Gustafsson Sweden 8 228 1.3× 54 1.4× 44 1.4× 11 0.4× 24 0.9× 12 327
Zihong Chen United States 4 172 1.0× 84 2.2× 12 0.4× 19 0.7× 12 0.4× 6 237
Tânia C.B. Santos Portugal 9 211 1.2× 10 0.3× 36 1.1× 21 0.7× 45 1.7× 15 324

Countries citing papers authored by Alison N. McCracken

Since Specialization
Citations

This map shows the geographic impact of Alison N. McCracken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison N. McCracken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison N. McCracken more than expected).

Fields of papers citing papers by Alison N. McCracken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison N. McCracken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison N. McCracken. The network helps show where Alison N. McCracken may publish in the future.

Co-authorship network of co-authors of Alison N. McCracken

This figure shows the co-authorship network connecting the top 25 collaborators of Alison N. McCracken. A scholar is included among the top collaborators of Alison N. McCracken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison N. McCracken. Alison N. McCracken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
McCracken, Alison N., et al.. (2025). It’s all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma. Journal of Neuro-Oncology. 172(2). 327–345. 7 indexed citations
2.
Finicle, Brendan T., Alexey S. Revenko, Brooke A. Anderson, et al.. (2023). Simultaneous inhibition of endocytic recycling and lysosomal fusion sensitizes cells and tissues to oligonucleotide therapeutics. Nucleic Acids Research. 51(4). 1583–1599. 16 indexed citations
3.
Kemp, Jessica A., David Chow, Michael T. Kleinman, et al.. (2020). Biocompatible Chemotherapy for Leukemia by Acid-Cleavable, PEGylated FTY720. Bioconjugate Chemistry. 31(3). 673–684. 7 indexed citations
4.
McCracken, Alison N., et al.. (2020). Synthetic Sphingolipids with 1,2-Pyridazine Appendages Improve Antiproliferative Activity in Human Cancer Cell Lines. ACS Medicinal Chemistry Letters. 11(5). 686–690. 12 indexed citations
5.
Hanessian, Stephen, et al.. (2019). Design, synthesis and anticancer activity of constrained sphingolipid-phenoxazine/phenothiazine hybrid constructs targeting protein phosphatase 2A. Bioorganic & Medicinal Chemistry Letters. 29(18). 2681–2685. 7 indexed citations
6.
Finicle, Brendan T., et al.. (2018). Sphingolipids inhibit endosomal recycling of nutrient transporters by inactivating ARF6. Journal of Cell Science. 131(12). 15 indexed citations
7.
Hanessian, Stephen, et al.. (2018). In search of constrained FTY720 and phytosphingosine analogs as dual acting anticancer agents targeting metabolic and epigenetic pathways. European Journal of Medicinal Chemistry. 159. 217–242. 8 indexed citations
8.
Kubiniok, Peter, Brendan T. Finicle, Alison N. McCracken, et al.. (2018). Dynamic Phosphoproteomics Uncovers Signaling Pathways Modulated by Anti-oncogenic Sphingolipid Analogs. Molecular & Cellular Proteomics. 18(3). 408–422. 14 indexed citations
9.
McCracken, Alison N., Seong Min Kim, Matheus P. Viana, et al.. (2016). Effects of stereochemistry, saturation, and hydrocarbon chain length on the ability of synthetic constrained azacyclic sphingolipids to trigger nutrient transporter down-regulation, vacuolation, and cell death. Bioorganic & Medicinal Chemistry. 24(18). 4390–4397. 12 indexed citations
10.
11.
Guenther, Garret, et al.. (2013). Loss of TSC2 confers resistance to ceramide and nutrient deprivation. Oncogene. 33(14). 1776–1787. 16 indexed citations
12.
McCracken, Alison N. & Aimee L. Edinger. (2013). Nutrient transporters: the Achilles’ heel of anabolism. Trends in Endocrinology and Metabolism. 24(4). 200–208. 90 indexed citations
13.
Fransson, Rebecca, et al.. (2013). Design, Synthesis, and Antileukemic Activity of Stereochemically Defined Constrained Analogues of FTY720 (Gilenya). ACS Medicinal Chemistry Letters. 4(10). 969–973. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyoung‐Soo Choi Breakdown of academic impact, for papers by Sheik Pran Babu Sardar Pasha Breakdown of academic impact, for papers by Yi Liao Breakdown of academic impact, for papers by Silvia Radenkovic Breakdown of academic impact, for papers by Jennifer Bolsée Breakdown of academic impact, for papers by Joshua Bliesath Breakdown of academic impact, for papers by Jicheng Duan Breakdown of academic impact, for papers by Robert Gustafsson Breakdown of academic impact, for papers by Zihong Chen Breakdown of academic impact, for papers by Tânia C.B. Santos
Rankless by CCL
2026